| Volume: | 24,664,695 |
|---|---|
| Day's Low: | $23.89 |
| 52-wk Low: | $17.23 |
| Previous Close: | $24.03 |
| Dividend: | $0.31 |
| Market Cap: | 47,603,000 |
| Avg Volume: | 11,143,000 |
|---|---|
| Day's High: | $24.50 |
| 52-wk High: | $24.63 |
| Open Price: | $23.92 |
| Yield: | 5.16% |
| P/E (Forward): | 11.84 |
| 1:25 PM | 11/17/2009 | UPDATE: FDA Warns Doctors On Using Plavix With Heartburn Meds |
| 11:13 AM | 11/17/2009 | FDA:Doctors Should Avoid Using Heartburn Medicines With Plavix |
| 8:45 PM | 11/15/2009 | Bristol-Myers Squibb Announces Split-Off Of Mead Johnson |
| 8:15 AM | 11/15/2009 | Proposed AstraZeneca Anticlotting Drug Better Than Plavix:Study |
| 12:09 PM | 11/12/2009 | Bristol-Myers, Armed With More Cash, Ready To Make Deals |
| 7:50 AM | 11/10/2009 | Bristol-Myers May Pay More Than $1 Billion In Drug-Rights Deal |
| 1:06 PM | 11/5/2009 | Amgen's Vectibix Misses Survival Goal,But Sales Could Benefit |
| 11/20/2009 | Exxon Mobil, Bristol-Myers Squibb: Money Flow Leaders (XOM, BMY) |
| 11/20/2009 | Bristol-Myers Faces Lower Sales |
| 11/18/2009 | It won't be a tough decision for patients to make. |
| 11/17/2009 | FDA Plavix Warning |
| 11/17/2009 | Bristol-Myers to Mead Johnson: It's time to walk on your own. |
| 11/17/2009 | Alkermes gains; Cerus, InterMune tumble |
| 11/17/2009 | FDA warns against taking Plavix with Prilosec |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.52 | 0.46 | 13.04 |
| EPS, GAAP | 0.48 | 1.29 | -62.79 |
| Consensus Estimate | 0.51 | 0.42 | 21.43 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 2.02 | 1.74 | 16.09 |
| EPS, GAAP | 1.92 | 1.95 | -1.54 |
| Consensus Estimate | 1.86 | NA | NA |
| BMY | Industry Average | |
| P/E (TTM) | 12.52 | 16.80 |
| P/E (Forward) | 11.84 | 1.10 |
| PEG Ratio | 1.60 | 0.07 |
| Price/Sales | 2.26 | 3.05 |
| Beta | 0.67 | 0.64 |